- Home
- CARA vs CLDI Comparison
CARA vs CLDI Comparison
Compare CARA & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARA
- CLDI
- Stock Information
- Founded
- CARA 2004
- CLDI 2014
- Country
- CARA United States
- CLDI United States
- Employees
- CARA N/A
- CLDI N/A
- Industry
- CARA Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CARA Health Care
- CLDI Health Care
- Exchange
- CARA Nasdaq
- CLDI Nasdaq
- Market Cap
- CARA 16.7M
- CLDI 18.1M
- IPO Year
- CARA 2014
- CLDI N/A
- Fundamental
- Price
- CARA $4.65
- CLDI $0.89
- Analyst Decision
- CARA Hold
- CLDI Strong Buy
- Analyst Count
- CARA 3
- CLDI 3
- Target Price
- CARA $12.00
- CLDI $16.67
- AVG Volume (30 Days)
- CARA 331.3K
- CLDI 1.2M
- Earning Date
- CARA 03-03-2025
- CLDI 03-14-2025
- Dividend Yield
- CARA N/A
- CLDI N/A
- EPS Growth
- CARA N/A
- CLDI N/A
- EPS
- CARA N/A
- CLDI N/A
- Revenue
- CARA $8,686,000.00
- CLDI N/A
- Revenue This Year
- CARA N/A
- CLDI N/A
- Revenue Next Year
- CARA N/A
- CLDI N/A
- P/E Ratio
- CARA N/A
- CLDI N/A
- Revenue Growth
- CARA N/A
- CLDI N/A
- 52 Week Low
- CARA $2.71
- CLDI $0.73
- 52 Week High
- CARA $13.80
- CLDI $16.80
- Technical
- Relative Strength Index (RSI)
- CARA 52.14
- CLDI 32.62
- Support Level
- CARA $4.32
- CLDI $0.83
- Resistance Level
- CARA $4.92
- CLDI $0.95
- Average True Range (ATR)
- CARA 0.66
- CLDI 0.12
- MACD
- CARA -0.10
- CLDI -0.03
- Stochastic Oscillator
- CARA 28.75
- CLDI 11.29
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.